Filing Flows › Sotera Health (SHC) › Q2 2026 › vs Q2 2025
Sotera Health (SHC) Q2 2026 vs Q2 2025 (year over year)
Sotera Health's revenue rose $27.0M (+9%) from $294M in Q2 2025 to $321M in Q2 2026. The biggest changes: Sterigenics +$16.7M (+9%); Nordion +$6.7M (+16%); Nelson Labs +$3.6M (+6%). Gross margin 55.4% against 56.6% (-1.2 pts).
Sotera Health, Q2 2026: revenue $321M (+9% year over year), operating margin 24.3%, net earnings $53.6M, operating cash flow $88.5M. The chart draws each line against Q2 2025, the increases inside each band.
Margins
| Q2 2026 | Q2 2025 | Change | |
|---|---|---|---|
| Gross margin | 55.4% | 56.6% | -1.2 pts |
| Operating margin | 24.3% | 6.4% | +17.9 pts |
| Net margin | 16.7% | 2.7% | +14.0 pts |
| Free cash flow margin | 13.1% | 8.9% | +4.2 pts |
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Sterigenics | $212M | $195M | $16.7M | +9% |
| Nelson Labs | $60.7M | $57.1M | $3.6M | +6% |
| Nordion | $49.1M | $42.4M | $6.7M | +16% |
| Revenue | $321M | $294M | $27.0M | +9% |
| Gross profit | $178M | $167M | $11.3M | +7% |
| Cost of revenue | $143M | $128M | $15.7M | +12% |
| Operating profit | $78.1M | $18.9M | $59.2M | +313% |
| Operating expenses | $99.9M | $148M | −$47.8M | -32% |
| Pre-tax earnings | $78.1M | $18.9M | $59.2M | +313% |
| SG&A | $68.2M | $68.9M | −$737K | -1% |
| Other operating costs | $31.8M | $78.8M | −$47.1M | -60% |
| Net earnings | $53.6M | $8.0M | $45.7M | +574% |
| Income tax | $24.4M | $10.9M | $13.5M | +123% |
| Depreciation & amortization | $33.4M | $35.0M | −$1.6M | -5% |
| Share-based compensation | $7.2M | $8.1M | −$901K | -11% |
| Working capital & other | $5.8M | −$6.3M | $12.1M | — |
| Operating cash flow | $88.5M | $57.4M | $31.1M | +54% |
| Free cash flow (OCF − capex) | $42.0M | $26.2M | $15.9M | +61% |
| Capital expenditures | $46.4M | $31.2M | $15.2M | +49% |
Questions
How much did Sotera Health's revenue grow year over year in Q2 2026?
Sotera Health's revenue rose $27.0M (+9%) from $294M in Q2 2025 to $321M in Q2 2026.
What drove Sotera Health's revenue change in Q2 2026?
Sterigenics +$16.7M (+9%); Nordion +$6.7M (+16%); Nelson Labs +$3.6M (+6%).